Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes

NCT04133922 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped the study drug could not be obtained

Conditions

Type 1 Diabetes
Insulin Sensitivity/Resistance

Interventions

DRUG: GLP-1
DRUG: Insulin
DRUG: Dextrose 20 % in Water

Sponsor

University of Virginia

Collaborators

[object Object]
[object Object]